FDA Grants Emergency Authorization For A 2nd COVID-19 Antibody Treatment
The experimental cocktail from the biotech company Regeneron is the same drug President Trump got when he was battling the coronavirus this year. It is designed for mild to moderate cases.
Copyright 2020 NPR
Corrected: November 21, 2020 at 10:00 PM MST
An earlier version of this story misspelled George Yancopoulos' last name as Yancopoulous.